These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19574588)
41. Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients. Malyszko J; Hryszko T; Malyszko JS; Wolczyński S; Myśliwiec M Transplant Proc; 2002 Dec; 34(8):3211-4. PubMed ID: 12493423 [No Abstract] [Full Text] [Related]
42. Prevalence of parvovirus B 19 infection in children with aplastic anemia. Gupta V; Saini I; Nath G Indian Pediatr; 2013 May; 50(5):489-91. PubMed ID: 23255678 [TBL] [Abstract][Full Text] [Related]
43. Parvovirus B19 infection in pregnancy. Eis-Hübinger AM; Dieck D; Schild R; Hansmann M; Schneweis KE Intervirology; 1998; 41(4-5):178-84. PubMed ID: 10213893 [TBL] [Abstract][Full Text] [Related]
44. A case of prolonged human parvovirus B19 DNA-emia associated with polyclonal B cell activation. Nobutoki T; Hori H; Higashigawa M; Azuma E; Sakurai M; Yoshizumi T; Nunoue T Acta Paediatr Jpn; 1996 Aug; 38(4):348-51. PubMed ID: 8840543 [TBL] [Abstract][Full Text] [Related]
45. Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection. Guillaume MP; Hermanus N; Peretz A Clin Rheumatol; 2002 Aug; 21(4):306-8. PubMed ID: 12189459 [TBL] [Abstract][Full Text] [Related]
46. [An exceptional cause of acute hepatitis in an adult: parvovirus B19]. Martínez González J; Senosiain Lalastra C; Mesonero Gismero F; Moreira Vicente V Gastroenterol Hepatol; 2012 Dec; 35(10):697-9. PubMed ID: 22749503 [TBL] [Abstract][Full Text] [Related]
47. Fatal parvovirus B19 myocarditis in children and possible dysimmune mechanism. Koehl B; Oualha M; Lesage F; Rambaud C; Canioni D; Hubert P; Leruez-Ville M Pediatr Infect Dis J; 2012 Apr; 31(4):418-21. PubMed ID: 22173134 [TBL] [Abstract][Full Text] [Related]
48. Human parvovirus B19 in cord blood of premature infants. Koga M; Matsuoka T; Katayama K; Takeda K; Nakata M; Sase M; Kato H; Furukawa S Am J Perinatol; 2001 Aug; 18(5):237-40. PubMed ID: 11552176 [TBL] [Abstract][Full Text] [Related]
56. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068 [TBL] [Abstract][Full Text] [Related]
57. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Cassinotti P; Siegl G Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):886-7. PubMed ID: 11152317 [No Abstract] [Full Text] [Related]
58. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. Page C; François C; Goëb V; Duverlie G J Clin Virol; 2015 Nov; 72():69-74. PubMed ID: 26433772 [TBL] [Abstract][Full Text] [Related]
59. Detection of parvovirus B19 in the lower respiratory tract. Costa C; Terlizzi ME; Solidoro P; Libertucci D; Bergallo M; Cavallo R J Clin Virol; 2009 Oct; 46(2):150-3. PubMed ID: 19632147 [TBL] [Abstract][Full Text] [Related]
60. Parvovirus glomerulonephritis in a patient with sickle cell disease. Tolaymat A; Al Mousily F; MacWilliam K; Lammert N; Freeman B Pediatr Nephrol; 1999 May; 13(4):340-2. PubMed ID: 10454787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]